Case Report
BibTex RIS Cite

Nadir Bir Nörolojik Bulgu Olarak Akut Hemiparezi ile Başvuran Çocukta Multisistem İnflamatuar Sendrom

Year 2024, Volume: 18 Issue: 2, 140 - 142, 18.03.2024
https://doi.org/10.12956/tchd.1244924

Abstract

Koronavirüs pandemisi tüm dünyayı etkisi altına alan ve milyonlarca insanın ölümüne neden olan en önemli hastalıklardan biri haline geldi. 2019 yılının sonunda başladığı için koronavirüs hastalığı-2019 (COVID-19) olarak adlandırılmıştır. COVID-19 pandemisi sonucu ortaya çıkan, yeni bir hastalık tanımı olan çocuklarda multisistem inflamatuar sendrom (MIS-C). MIS-C'nin birçok farklı semptoma neden olduğu bilinmesine rağmen, literatürde daha fazla makale ve vaka sunumu yayınlandıkça bilgimiz katlanarak artacaktır. MIS-C birçok sistemi etkilemekle birlikte çeşitli nörolojik tutulumlar da bildirilmiştir. Ancak literatüre göre şimdiye kadar MIS-C'de hemiparezisi olan bir olgu bildirilmemiştir. Bildiğimiz kadarıyla MIS-C tanısında intrakraniyal patoloji olmaksızın hemiparezi ile başvuran nadir bir olgudur.

References

  • Martins MM, Prata-Barbosa A, Ledo Alves da Cunha AJ. Update on SARS-CoV-2 infection in children. Paediatrics and International Child Health 2021;41;56-64.
  • Panigrahy N, Policarpio J, Ramanathan R. Multisystem inflammatory syndrome in children and SARS-CoV-2: A scoping review. Pediatr Rehabil Med 2020;13:301-16.
  • Loke Y-HY-H, Berul CICI, Harahsheh ASAS. Multisystem inflammatory syndrome in children: is there a linkage to Kawasaki disease? Trends Cardiovasc Med 2020; 30: 389–96.
  • Information for Healthcare Providers about Multisystem Inflammatory Syndrome in Children (MIS-C) | CDC. Full text: https://www.cdc.gov/mis-c/hcp/ (accessed 12 August 2020).
  • Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet 2020; 395: 1607–8.
  • Licciardi F, Pruccoli G, Denina M, Parodi E, Taglietto M, Rosati S, et al. SARS-CoV-2-Induced Kawasaki-Like Hyperinflammatory Syndrome: A Novel COVID Phenotype in Children. Pediatrics 2020;146: e20201711.
  • Romero-Sánchez CM, Díaz-Maroto I, Fernández-Díaz E. Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry. Neurology 2020;95:1060-70.
  • Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol 2020;77:683-90.
  • Panda PK, Sharawat IK, Panda P, Natarajan V, Bhakat R, Dawman L. Neurological Complications of SARS-CoV-2 Infection in Children: A Systematic Review and Meta-Analysis. J Trop Pediatr 20201; 67:fmaa070.
  • Susanna Esposito, Nicola Principi. Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2. Pediatric Drugs 2021;23:119–29.
  • Dufort EM, Koumans EH, Chow EJ, Rosenthal EM, Muse A, Rowlands J, et al. Multisystem Inflammatory Syndrome in Children in New York State. N Engl J Med 2020;383:347-58.
  • Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P, et al. Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. JAMA 2020;324:259-69.
  • Kaushik A, Gupta S, Sood M, Sharman S, Verma S. A Systematic Review of Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 Infection. Pediatr Infect Dis J 2020;39:340-6. 
  • Radia T, Williams N, Agrawal P, Harman K, Weale J, Cook J, et al. A. Multi-system inflammatory syndrome in children&adolescents (MIS-C): A systematic review of clinical features and presentation. Paediatr Respir Rev 2020;38: 51-7.
  • Cirks BT, Rowe SJ, Jiang SY, Brooks R, Mulreany MP, Hoffner W, et al. 16 Weeks Later: Expanding the Risk Period for MIS-C. J Pediatric Infect Dis Soc 2021;10: 686–90.
  • Abdel-Mannan O, Eyre M, Löbel U, Bamford A, Eltze C, Hameed B, et al. Neurologic and Radiographic Findings Associated With COVID-19 Infection in Children. JAMA Neurol 2020;77:1440-5.
  • LaRovere KL, Riggs BJ, Poussaint TY, Yonug CC, Newhams MM, Maamari M, et al. Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome. JAMA Neurol 2021;78:536-47.
  • Sa M, Mirza L, Carter M, Carlton Jones L, Gowda V, Handforth J, et al. Study Group. Systemic Inflammation Is Associated With Neurologic Involvement in Pediatric Inflammatory Multisystem Syndrome Associated With SARS-CoV-2. Neurol Neuroimmunol Neuroinflamm 2021 13;8:e999.
  • Chinnabhandar V, Singh A, Mandal A, Parmar BJ. Acute Hemiplegia in Children: A Prospective Study of Etiology, Clinical Presentation, and Outcome from Western India. J Neurosci Rural Pract 2018;9:504-9.
  • Nandyala A, Shah T, Ailani J. Hemiplegic Migraine. Curr Neurol Neurosci Rep 2023 ;23:381-7.

Multisystem Inflammatory Syndrome in a Child Presenting with Acute Hemiparesis as a Rare Neurologic Manifestation

Year 2024, Volume: 18 Issue: 2, 140 - 142, 18.03.2024
https://doi.org/10.12956/tchd.1244924

Abstract

Coronavirus pandemic has become one of the most important illness affecting all over the world and causing the death of millions of people. Because it started at the end of 2019 it named as coronavirus disease-2019 (COVID-19). Multisystem inflammatory syndrome in children (MIS-C), which is a new disease definition, that has emerged as a result of the COVID-19 pandemic. Although it is known that MIS-C causes many different symptoms, our knowledge will increase exponentially as more articles and case reports continue to published to the literature. Although MIS-C affects many systems, various neurological involvement has also been reported. But, according to literature, no case with hemiparesis in MIS-C has been reported so far. To the best of our knowledge this is the case presenting with hemiparesis without intracranial pathology in the diagnosis of MIS-C.

References

  • Martins MM, Prata-Barbosa A, Ledo Alves da Cunha AJ. Update on SARS-CoV-2 infection in children. Paediatrics and International Child Health 2021;41;56-64.
  • Panigrahy N, Policarpio J, Ramanathan R. Multisystem inflammatory syndrome in children and SARS-CoV-2: A scoping review. Pediatr Rehabil Med 2020;13:301-16.
  • Loke Y-HY-H, Berul CICI, Harahsheh ASAS. Multisystem inflammatory syndrome in children: is there a linkage to Kawasaki disease? Trends Cardiovasc Med 2020; 30: 389–96.
  • Information for Healthcare Providers about Multisystem Inflammatory Syndrome in Children (MIS-C) | CDC. Full text: https://www.cdc.gov/mis-c/hcp/ (accessed 12 August 2020).
  • Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet 2020; 395: 1607–8.
  • Licciardi F, Pruccoli G, Denina M, Parodi E, Taglietto M, Rosati S, et al. SARS-CoV-2-Induced Kawasaki-Like Hyperinflammatory Syndrome: A Novel COVID Phenotype in Children. Pediatrics 2020;146: e20201711.
  • Romero-Sánchez CM, Díaz-Maroto I, Fernández-Díaz E. Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry. Neurology 2020;95:1060-70.
  • Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol 2020;77:683-90.
  • Panda PK, Sharawat IK, Panda P, Natarajan V, Bhakat R, Dawman L. Neurological Complications of SARS-CoV-2 Infection in Children: A Systematic Review and Meta-Analysis. J Trop Pediatr 20201; 67:fmaa070.
  • Susanna Esposito, Nicola Principi. Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2. Pediatric Drugs 2021;23:119–29.
  • Dufort EM, Koumans EH, Chow EJ, Rosenthal EM, Muse A, Rowlands J, et al. Multisystem Inflammatory Syndrome in Children in New York State. N Engl J Med 2020;383:347-58.
  • Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P, et al. Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. JAMA 2020;324:259-69.
  • Kaushik A, Gupta S, Sood M, Sharman S, Verma S. A Systematic Review of Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 Infection. Pediatr Infect Dis J 2020;39:340-6. 
  • Radia T, Williams N, Agrawal P, Harman K, Weale J, Cook J, et al. A. Multi-system inflammatory syndrome in children&adolescents (MIS-C): A systematic review of clinical features and presentation. Paediatr Respir Rev 2020;38: 51-7.
  • Cirks BT, Rowe SJ, Jiang SY, Brooks R, Mulreany MP, Hoffner W, et al. 16 Weeks Later: Expanding the Risk Period for MIS-C. J Pediatric Infect Dis Soc 2021;10: 686–90.
  • Abdel-Mannan O, Eyre M, Löbel U, Bamford A, Eltze C, Hameed B, et al. Neurologic and Radiographic Findings Associated With COVID-19 Infection in Children. JAMA Neurol 2020;77:1440-5.
  • LaRovere KL, Riggs BJ, Poussaint TY, Yonug CC, Newhams MM, Maamari M, et al. Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome. JAMA Neurol 2021;78:536-47.
  • Sa M, Mirza L, Carter M, Carlton Jones L, Gowda V, Handforth J, et al. Study Group. Systemic Inflammation Is Associated With Neurologic Involvement in Pediatric Inflammatory Multisystem Syndrome Associated With SARS-CoV-2. Neurol Neuroimmunol Neuroinflamm 2021 13;8:e999.
  • Chinnabhandar V, Singh A, Mandal A, Parmar BJ. Acute Hemiplegia in Children: A Prospective Study of Etiology, Clinical Presentation, and Outcome from Western India. J Neurosci Rural Pract 2018;9:504-9.
  • Nandyala A, Shah T, Ailani J. Hemiplegic Migraine. Curr Neurol Neurosci Rep 2023 ;23:381-7.
There are 20 citations in total.

Details

Primary Language English
Subjects ​Internal Diseases
Journal Section CASE REPORTS
Authors

Nihal Yıldız 0000-0003-0989-842X

Zeynep Gökçe Gayretli Aydın 0000-0003-4291-1067

Beril Dilber 0000-0002-7633-0060

Osman Yeşilbaş 0000-0002-4290-0491

Early Pub Date February 29, 2024
Publication Date March 18, 2024
Submission Date August 31, 2023
Published in Issue Year 2024 Volume: 18 Issue: 2

Cite

Vancouver Yıldız N, Gayretli Aydın ZG, Dilber B, Yeşilbaş O. Multisystem Inflammatory Syndrome in a Child Presenting with Acute Hemiparesis as a Rare Neurologic Manifestation. Türkiye Çocuk Hast Derg. 2024;18(2):140-2.


The publication language of Turkish Journal of Pediatric Disease is English.


Manuscripts submitted to the Turkish Journal of Pediatric Disease will go through a double-blind peer-review process. Each submission will be reviewed by at least two external, independent peer reviewers who are experts in the field, in order to ensure an unbiased evaluation process. The editorial board will invite an external and independent editor to manage the evaluation processes of manuscripts submitted by editors or by the editorial board members of the journal. The Editor in Chief is the final authority in the decision-making process for all submissions. Articles accepted for publication in the Turkish Journal of Pediatrics are put in the order of publication, with at least 10 original articles in each issue, taking into account the acceptance dates. If the articles sent to the reviewers for evaluation are assessed as a senior for publication by the reviewers, the section editor and the editor considering all aspects (originality, high scientific quality and citation potential), it receives publication priority in addition to the articles assigned for the next issue.


The aim of the Turkish Journal of Pediatrics is to publish high-quality original research articles that will contribute to the international literature in the field of general pediatric health and diseases and its sub-branches. It also publishes editorial opinions, letters to the editor, reviews, case reports, book reviews, comments on previously published articles, meeting and conference proceedings, announcements, and biography. In addition to the field of child health and diseases, the journal also includes articles prepared in fields such as surgery, dentistry, public health, nutrition and dietetics, social services, human genetics, basic sciences, psychology, psychiatry, educational sciences, sociology and nursing, provided that they are related to this field. can be published.